{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T22:52:01Z","timestamp":1775861521401,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00467"],"award-info":[{"award-number":["PI21\/00467"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.nrleng.2022.10.001","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T06:22:06Z","timestamp":1665123726000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A variant in GRN of Spanish origin presenting with heterogeneous phenotypes"],"prefix":"10.1016","volume":"40","author":[{"given":"M.","family":"Men\u00e9ndez-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Fern\u00e1ndez-Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pitiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2022.10.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2020.07.014","article-title":"Underlying genetic variation in familial frontotemporal dementia: sequencing of 198 patients","volume":"97","author":"Mol","year":"2021","journal-title":"Neurobiol Aging"},{"issue":"11","key":"10.1016\/j.nrleng.2022.10.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200860","article-title":"Differences in motor features of c9orf72, MAPT, or GRN variant carriers with familial frontotemporal lobar degeneration","volume":"9","author":"Tipton","year":"2022","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nrleng.2022.10.001_bib0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp.2010.212225","article-title":"Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review","volume":"82","author":"Seelaar","year":"2011","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"1","key":"10.1016\/j.nrleng.2022.10.001_bib0020","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1212\/WNL.0000000000012174","article-title":"Primary progressive aphasia associated with GRN mutations: new insights into the nonamyloid logopenic variant","volume":"97","author":"Saracino","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nrleng.2022.10.001_bib0025","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/archneurol.2011.53","article-title":"Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration","volume":"68","author":"Chen-Plotkin","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrleng.2022.10.001_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnagi.2015.00171","article-title":"Phenotypic heterogeneity of monogenic frontotemporal dementia","volume":"7","author":"Benussi","year":"2015","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"10.1016\/j.nrleng.2022.10.001_bib0035","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.neurobiolaging.2013.10.097","article-title":"Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation","volume":"35","author":"Bonvicini","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"Pt 3","key":"10.1016\/j.nrleng.2022.10.001_bib0040","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/brain\/awn012","article-title":"Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study","volume":"131","author":"Le Ber","year":"2008","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.nrleng.2022.10.001_bib0045","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2007.08.022","article-title":"Prominent phenotypic variability associated with mutations in Progranulin","volume":"30","author":"Kelley","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.nrleng.2022.10.001_bib0050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tig.2008.01.004","article-title":"Loss of progranulin function in frontotemporal lobar degeneration","volume":"24","author":"Cruts","year":"2008","journal-title":"Trends Genet"},{"issue":"39","key":"10.1016\/j.nrleng.2022.10.001_bib0055","doi-asserted-by":"crossref","first-page":"32298","DOI":"10.1074\/jbc.R112.399170","article-title":"Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration","volume":"287","author":"Cenik","year":"2012","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.nrleng.2022.10.001_bib0060","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab095","article-title":"Evidence for GRN connecting multiple neurodegenerative diseases","volume":"3","author":"Nalls","year":"2021","journal-title":"Brain Commun"},{"issue":"5","key":"10.1016\/j.nrleng.2022.10.001_bib0065","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/hmg\/ddz229","article-title":"Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity","volume":"29","author":"Valdez","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.nrleng.2022.10.001_bib0070","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ejhg.2013.37","article-title":"Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration","volume":"21","author":"Chiang","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nrleng.2022.10.001_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2015.10.029","article-title":"Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features","volume":"38","author":"Karch","year":"2016","journal-title":"Neurobiol Aging."},{"issue":"2","key":"10.1016\/j.nrleng.2022.10.001_bib0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archneurol.2009.328","article-title":"The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration","volume":"67","author":"Yu","year":"2010","journal-title":"Arch Neurol"},{"issue":"10","key":"10.1016\/j.nrleng.2022.10.001_bib0085","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/mds.27812","article-title":"Parkinsonism and spastic paraplegia type 7: expanding the spectrum of mitochondrial Parkinsonism","volume":"34","author":"De la Casa-Fages","year":"2019","journal-title":"Mov Disord"},{"issue":"2\u20133","key":"10.1016\/j.nrleng.2022.10.001_bib0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/1066527041410418","article-title":"Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals","volume":"11","author":"Yeo","year":"2004","journal-title":"J Comput Biol"},{"issue":"14","key":"10.1016\/j.nrleng.2022.10.001_bib0095","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1167\/iovs.19-27470","article-title":"Expanding the genetic landscape of usher-like phenotypes","volume":"60","author":"Fuster-Garc\u00eda","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.nrleng.2022.10.001_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031039","article-title":"Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer\u2019s disease families","volume":"7","author":"Cruchaga","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.nrleng.2022.10.001_bib0105","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/jnnp.2006.109553","article-title":"Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes","volume":"78","author":"Schymick","year":"2007","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"3","key":"10.1016\/j.nrleng.2022.10.001_bib0110","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.neuroimage.2009.12.088","article-title":"Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations","volume":"53","author":"Rohrer","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.nrleng.2022.10.001_bib0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fneur.2018.00335","article-title":"Frontotemporal lobe degeneration as origin of scans without evidence of dopaminergic deficit","volume":"9","author":"Men\u00e9ndez-Gonz\u00e1lez","year":"2018","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.nrleng.2022.10.001_bib0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-017-0334-y","article-title":"Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family","volume":"10","author":"Sieben","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.nrleng.2022.10.001_bib0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2020.09.019","article-title":"Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations","volume":"80","author":"Carneiro","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"10.1016\/j.nrleng.2022.10.001_bib0130","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","article-title":"A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease","volume":"53","author":"Wightman","year":"2021","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.nrleng.2022.10.001_bib0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/brain\/awz377","article-title":"Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms","volume":"143","author":"Huin","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nrleng.2022.10.001_bib0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40478-017-0480-2","article-title":"Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis","volume":"5","author":"Tan","year":"2017","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"10.1016\/j.nrleng.2022.10.001_bib0145","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.molmed.2017.08.004","article-title":"Modifiers of GRN-associated frontotemporal lobar degeneration","volume":"23","author":"Wauters","year":"2017","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.nrleng.2022.10.001_bib0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40478-021-01234-2","article-title":"Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia","volume":"9","author":"Natarajan","year":"2021","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"10.1016\/j.nrleng.2022.10.001_bib0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000333132","article-title":"Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study","volume":"9","author":"Ghidoni","year":"2012","journal-title":"Neurodegener Dis"},{"issue":"6","key":"10.1016\/j.nrleng.2022.10.001_bib0160","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2174\/1567205013666160314151247","article-title":"Serum levels of progranulin do not reflect cerebrospinal fluid levels in neurodegenerative disease","volume":"13","author":"Wilke","year":"2016","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"10.1016\/j.nrleng.2022.10.001_bib0165","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1471-4159.2009.06546.x","article-title":"Pathogenic cysteine mutations affect progranulin function and production of mature granulins","volume":"112","author":"Wang","year":"2010","journal-title":"J Neurochem"},{"issue":"7","key":"10.1016\/j.nrleng.2022.10.001_bib0170","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab437","article-title":"Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations","volume":"145","author":"Pottier","year":"2021","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.nrleng.2022.10.001_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2021.11.015","article-title":"Progranulin as a therapeutic target in neurodegenerative diseases","volume":"43","author":"Rhinn","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nrleng.2022.10.001_bib0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.conb.2021.10.001","article-title":"New insights and therapeutic opportunities for progranulin-deficient frontotemporal dementia","volume":"72","author":"Amin","year":"2022","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.nrleng.2022.10.001_bib0185","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.713031","article-title":"Tweaking progranulin expression: therapeutic avenues and opportunities","volume":"14","author":"Terryn","year":"2021","journal-title":"Front Mol Neurosci"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580822001122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580822001122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T12:03:44Z","timestamp":1737806624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580822001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2173580822001122"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2022.10.001","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A variant in GRN of Spanish origin presenting with heterogeneous phenotypes","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2022.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Neurolog\u00eda.","name":"copyright","label":"Copyright"}]}}